Bifidobacterium Longum Market - Global Industry Research Analysis

According to Market Research Store, the global bifidobacterium longum market size was valued at around USD 1072.40 million in 2023 and is estimated to reach USD 2397.81 million by 2032, to register a CAGR of approximately 8.40% in terms of revenue during the forecast period 2024-2032.

To Get more Insights, Request a Free Sample

The bifidobacterium longum report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

Global Bifidobacterium Longum Market: Overview

Bifidobacterium longum is a species of probiotic bacteria naturally found in the human gastrointestinal tract, particularly in the intestines. It is known for promoting digestive health by balancing gut microbiota, aiding in digestion, and enhancing the immune system.

As a beneficial bacterium, it helps break down carbohydrates and fight harmful pathogens in the gut, contributing to overall gut health. Bifidobacterium longum is commonly included in probiotic supplements and functional foods to support digestive and immune function. It is also linked to reducing inflammation and helping manage conditions such as irritable bowel syndrome (IBS) and lactose intolerance.

The market for Bifidobacterium longum is growing significantly due to increasing awareness of gut health and the rising demand for probiotics in supplements and functional foods. Consumers are increasingly seeking probiotics to improve digestion, enhance immune function, and support general well-being.

Key Highlights

• The bifidobacterium longum market is anticipated to grow at a CAGR of 8.40% during the forecast period.
• The global bifidobacterium longum market was estimated to be worth approximately USD 1072.40 million in 2023 and is projected to reach a value of USD 2397.81 million by 2032.
• The growth of the bifidobacterium longum market is being driven by growing consumer awareness of gut health benefits, rising demand for probiotics in functional foods and beverages, and advancements in probiotic delivery technologies.
• Based on the type, the 0.2g/Piece segment is growing at a high rate and is projected to dominate the market.
• On the basis of application, the dietary supplements segment is projected to swipe the largest market share.
• In terms of end-users, the human segment is expected to dominate the market.
• Based on the distributional channel, the online stores segment is expected to lead the global market.
• By region, Asia-Pacific is expected to dominate the global market during the forecast period.

Bifidobacterium Longum Market: Dynamics

Key Growth Drivers

• Increasing awareness of gut health: Growing consumer awareness of the importance of gut health and its impact on overall well-being is driving the demand for probiotics like Bifidobacterium longum.
• Expanding applications beyond digestive health: Bifidobacterium longum is being used in a wider range of applications, including immune health, skin health, and infant formula.
• Advancements in probiotic technology: Innovations in probiotic delivery systems and formulations are improving the efficacy and stability of Bifidobacterium longum products.
• Rising demand for natural and organic products: Consumers are increasingly seeking natural and organic products, including probiotics, leading to increased demand for Bifidobacterium longum.  

Restraints

• Regulatory challenges: Compliance with regulatory standards for probiotics can be complex and costly, especially in different regions.
• Competition from other probiotic strains: Bifidobacterium longum faces competition from other probiotic strains, such as Lactobacillus and Saccharomyces boulardii.
• Limited scientific evidence for specific health benefits: While there is growing evidence for the benefits of Bifidobacterium longum, more research is needed to establish its efficacy for specific health conditions.
• Consumer skepticism: Some consumers may be skeptical about the benefits of probiotics, limiting their adoption.

Opportunities

• Expanding applications in emerging markets: The growing middle class in emerging markets presents opportunities for the growth of the Bifidobacterium longum market.
• Integration with other food and beverage products: Bifidobacterium longum can be incorporated into a variety of food and beverage products, such as yogurt, fermented drinks, and supplements.
• Development of new probiotic formulations: Innovations in probiotic technology can lead to the development of new Bifidobacterium longum formulations with enhanced benefits.
• Growing demand for personalized nutrition: The increasing focus on personalized nutrition presents opportunities for the development of customized probiotic products containing Bifidobacterium longum.

Challenges

• Market volatility: The market for Bifidobacterium longum can be subject to fluctuations due to economic conditions, consumer trends, and regulatory changes.
• Competitive landscape: The market is competitive, with numerous players offering Bifidobacterium longum products.
• Technological advancements: The rapid pace of technological advancements can make it difficult for manufacturers to keep up with the latest innovations and maintain a competitive edge.
• Supply chain disruptions: Disruptions in the supply chain, such as shortages of raw materials or production challenges, can impact the availability and pricing of Bifidobacterium longum products.

Bifidobacterium Longum Market: Segmentation Insights

The global bifidobacterium longum market is divided by type, application, end-users, distribution channel, and region.

Segmentation Insights by Type

Based on Type, the global bifidobacterium longum market is divided into 0.2g/Piece and 0.25g/Piece.

The 0.2g/Piece segment is likely the dominant market segment due to its suitability for general wellness and daily health maintenance. 0.2g/Piece refers to a dosage where each individual unit or capsule contains 0.2 grams of Bifidobacterium longum. This dosage is common in dietary supplements and probiotics targeted at maintaining general digestive health, immune support, and overall well-being. It is often used in formulations designed for daily consumption, catering to consumers looking for consistent, moderate supplementation.

However, the 0.25g/Piece segment is growing in importance, particularly in the therapeutic and targeted health markets where higher probiotic doses are required for treating specific gastrointestinal or immune-related conditions. 0.25g/Piece refers to a slightly higher dosage per unit or capsule, providing 0.25 grams of Bifidobacterium longum. It is increasingly popular among consumers who require higher doses for more immediate or intensive probiotic support.

Segmentation Insights by Application

On the basis of Application, the global bifidobacterium longum market is bifurcated into dietary supplements, pharmaceuticals, functional food & beverages, animal feed, and others.

The Dietary Supplements segment dominates the market due to widespread consumer use of probiotics for daily gut health and overall wellness. Dietary supplements are one of the largest applications for Bifidobacterium longum. As a probiotic, it is widely included in capsules, powders, and tablets aimed at improving gut health, boosting immunity, and supporting digestive function. These supplements are often targeted at consumers looking to maintain overall health or address specific digestive issues.

The Pharmaceuticals segment is growing as medical professionals and researchers recognize the therapeutic potential of probiotics like Bifidobacterium longum. These products are used to prevent or treat conditions like IBS, diarrhea, and immune system imbalances. Pharmaceuticals containing Bifidobacterium longum are used in the treatment and management of various health conditions, including gastrointestinal disorders, immune deficiencies, and infections.

The Functional Food & Beverages segment is a fast-growing part of the Bifidobacterium longum market, driven by consumer preferences for health-conscious food options that support digestive health. This segment includes a wide range of products, from dairy-based to plant-based functional foods and beverages. Functional foods and beverages containing Bifidobacterium longum are designed to provide additional health benefits beyond basic nutrition.

The Animal Feed segment is growing as more farmers and pet owners become aware of the benefits of probiotics for animal health. Bifidobacterium longum is included in feeds and supplements for various animals, including cattle, poultry, swine, and pets like dogs and cats.

Segmentation Insights by End-Users

In terms of End-Users, the global bifidobacterium longum market is categorized into human and animals.

The Human segment holds a significant share of the Bifidobacterium longum market, particularly in the areas of dietary supplements and functional foods. The increasing prevalence of digestive health issues, the aging population, and the rising interest in gut microbiome health have fueled the demand for probiotics in this segment. It is widely recognized for its ability to support gut health, boost immunity, and help manage various gastrointestinal disorders.

The Animal segment is growing rapidly as more farmers and pet owners recognize the benefits of probiotics for animal health. Bifidobacterium longum is also used in the Animal sector, particularly in livestock feed and pet supplements. It is included in formulations designed to promote gut health, improve digestion, and enhance the overall health and well-being of animals. The use of probiotics in animal feed has grown significantly in recent years, especially as the industry moves away from the use of antibiotics in livestock farming.

Segmentation Insights by Distribution Channel

By Distribution Channel, the global bifidobacterium longum market is splits into online stores, supermarkets/hypermarkets, specialty stores, and others.

The Online Stores segment is growing rapidly, particularly as more consumers turn to e-commerce for health and wellness products. The convenience of online shopping, especially during and after the COVID-19 pandemic, has further accelerated this trend. Online platforms provide a wide range of products, including various forms of Bifidobacterium longum supplements, functional foods, and probiotics for pets.

The Supermarkets/Hypermarkets segment holds a significant share of the Bifidobacterium longum market, particularly in the functional foods category. These retail outlets are a convenient option for consumers who prefer to buy groceries and health products in one place. Supermarkets also provide a platform for new product launches and in-store promotions.

Specialty Stores represent a smaller but important segment of the market, especially for consumers seeking high-quality, therapeutic, or organic probiotic products. These stores offer personalized customer service and often carry premium products that may not be available in supermarkets or online.

Bifidobacterium Longum Market: Report Scope

0 , , ,

Bifidobacterium Longum Market: Regional Insights

• Asia-Pacific dominates the Bifidobacterium Longum market

Asia-Pacific leads the global market due to its large population and increasing health consciousness. Countries like China, Japan, and India are witnessing rapid adoption of Bifidobacterium-based probiotic products, driven by growing demand for functional foods and dietary supplements. The region is expected to experience robust growth, supported by an expanding middle class and rising disposable incomes.

North America is a significant market, particularly in the United States and Canada, where the demand for dietary supplements is high. The aging population and growing interest in preventive health are key factors driving the adoption of Bifidobacterium-based products. Additionally, the strong presence of leading probiotic manufacturers further supports market expansion in this region.

Europe is another major player in the Bifidobacterium Longum market, with countries like Germany, France, and the UK being key contributors. The region's stringent regulations on food safety and increasing consumer demand for natural and organic products are propelling the market. European consumers are particularly drawn to probiotics for digestive and immune health, with a growing preference for products that support overall well-being.

Latin America and Middle East & Africa (MEA) regions are emerging markets for Bifidobacterium Longum, driven by increasing awareness of probiotic benefits and improving healthcare infrastructure. Brazil, Argentina, and South Africa are seeing growing demand, although the market remains smaller compared to APAC and North America.

Recent Developments:

In January 2023, Nissin Foods Group, renowned for its cup noodles in Japan, ventured into producing Foods with Function Claims (FFCs) to capitalize on the growing understanding of the gut-brain connection and address the rising demand for IBS-specific products. For the first time, the company introduced lactic acid bacteria into its product line, launching two FFCs: Bifidobacterium N61, designed to alleviate stomach pain, and Bifidobacterium N708, formulated to enhance memory and concentration.

Bifidobacterium Longum Market: Competitive Landscape

The report provides an in-depth analysis of companies operating in the bifidobacterium longum market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.

Some of the major players in the global bifidobacterium longum market include:

• ATCC Inc
• Bifodan A/S.
• BioCare Copenhagen ApS
• Biofodan A/S
• BioGaia AB
• Chr. Hansen Holding A/S
• Danisco A/S
• Danone SA
• Deerland Enzymes Inc.
• DuPont de Nemours, Inc.
• Hanson Ltd
• Kerry Group
• Lallemand Inc.
• Morinaga Milk Industry Co., Ltd.
• Mystic Pharmaceuticals Inc
• Nestlé S.A.
• Probi AB
• Yakult Honsha Co., Ltd.

The global bifidobacterium longum market is segmented as follows:

By Type

• 0.2g/Piece
• 0.25g/Piece

By Application

• Dietary Supplements
• Functional Food & Beverages
• Animal Feed
• Pharmaceuticals
• Others

By End-Users

• Humans
  • Adults
  • Children
  • Infants
• Animals

By Distribution Channel

• Online Stores
• Supermarkets/Hypermarkets
• Specialty Stores
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa

Frequently Asked Questions